Unveiling biomarkers of telitacicept’s efficacy in SLE treatment through proteomics and metabolomics
The above results reveal biomarkers related to the differential efficacy of Telitacicept in treating SLE patients and potential mechanisms underlying these differences, which may provide a reference for personalized treatment and mechanistic research in SLE.
Authors
- Hanhan Chen
- Siyuan Chang
- Jiahui Shi (ORCID: https://orcid.org/0000-0003-0342-133X)
- Huiyu Nie
- Shu Li
- Jia Wang
- Wei Cheng
- Fen Li
- Yan Ge
- Xiaofei Peng
- Qi Tang
Institutions
- Central South University (CN)
- Autoimmune Technologies (United States) (US)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/fimmu.2026.1779880
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bethune Charitable Foundation